The preliminary trial of a drug called ulixertinib was conducted with 135 patients who had already failed treatments for one of a variety of advanced, solid tumors.Researchers led by Dr. Ryan Sullivan, of Massachusetts General Hospital, said ulixertinib did seem to spur at least a “partial response” to the therapy or “disease stabilization,” regardless of
When families travel during the holidays, they must contend with crowds, traffic and unfamiliar surroundings. But children’s safety should always come first, a leading pediatricians’ group says.When taking a train or airplane, it may seem inconvenient to have to worry about car safety seats. But the American Academy of Pediatrics (AAP) recommends that parents make